相关实验视频
Updated: Jul 6, 2026

07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
48.0K
慢性咳中的卡帕和穆阿片类受体:当前证据和未来治疗方法
Surinder S Birring1, Peter V Dicpinigaitis2, Toby M Maher3
1Centre for Human & Applied Physiological Sciences, School of Basic & Medical Biosciences, King's College London, London, UK.
Lung
|May 13, 2025
概括
新的研究探索了向卡帕和mu阿片类受体来治疗慢性咳. 双重作用的卡帕激动剂/mu对抗剂可以在没有传统治疗的滥用潜力的情况下提供有效的咳缓解.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性咳显著影响患者的生活质量和健康结果.
- 慢性咳病原体的确切机制,包括神经过敏,尚未完全理解.
- 阿片类受体 (kappa和mu) 与咳的神经通路有关.
研究的目的:
- 审查咳过敏的机制.
- 检查卡帕和穆阿片类受体在咳神经生理学中的作用.
- 评估针对这些受体用于新型慢性咳管理的临床潜力.
主要方法:
- 关于慢性咳机制的当前研究的文献综述.
- 对卡帕和穆阿片类受体在咳反射中的神经生理学作用的分析.
- 评估针对这些阿片类受体的治疗策略.
主要成果:
- 阿片类受体在咳的外围和中央神经通路中起着关键作用.
- 类阿片受体agonists,像吗啡,可以调节咳,但携带呼吸系统抑郁和滥用的风险.
- 双重作用的卡帕受体激动剂和受体对抗剂在没有滥用潜力的咳管理方面表现有前途.
结论:
- 向卡帕和穆阿片类受体代表了慢性咳的新疗法.
- 双作用的kappa/mu受体调节器可以提供有效的咳抑制,并改善安全性.
- 需要进一步的临床研究来验证这些发现用于慢性咳治疗.
相关概念视频
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

